LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,216,771 | +10.5% | 47,890 | +13.5% | 0.01% | +12.5% |
| Q2 2023 | $2,912,376 | +110.5% | 42,190 | +47.1% | 0.01% | +100.0% |
| Q1 2023 | $1,383,432 | -12.5% | 28,690 | -9.5% | 0.00% | -20.0% |
| Q4 2022 | $1,581,965 | +45.3% | 31,690 | +18.7% | 0.01% | +66.7% |
| Q3 2022 | $1,089,000 | -45.9% | 26,700 | -27.0% | 0.00% | -50.0% |
| Q2 2022 | $2,013,000 | +6.5% | 36,600 | -29.7% | 0.01% | +20.0% |
| Q1 2022 | $1,891,000 | +65.6% | 52,039 | +112.4% | 0.01% | +66.7% |
| Q4 2021 | $1,142,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |